HC Advisors’s Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share TINV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80,391
Closed -$55K 92
2022
Q3
$55K Hold
80,391
0.04% 84
2022
Q2
$38K Hold
80,391
0.03% 80
2022
Q1
$33K Buy
80,391
+16,500
+26% +$8.32K 0.02% 83
2021
Q4
$45K Buy
63,891
+8,280
+15% +$6.19K 0.03% 84
2021
Q3
$39K Buy
55,611
+1,750
+3% +$1.54K 0.03% 79
2021
Q2
$60K Buy
53,861
+14,481
+37% +$15.9K 0.04% 81
2021
Q1
$51K Buy
+39,380
New +$72.8K 0.03% 88

HC Advisors's TINV.WS Position: Q4 2022 in Review

HC Advisors sold out of Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (TINV.WS) in Q4 2022, closing a stake of 80,391 shares — an estimated $55K sold.

HC Advisors first reported a position in TINV.WS in Q1 2021 and held it in 7 quarters. The position peaked at $60K in Q2 2021. 0 funds tracked by Wall St. Rank hold TINV.WS as of Q4 2022.

  • HC Advisors reported no remaining Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • HC Advisors sold 80,391 Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q4 2022, an estimated $55K.
  • HC Advisors first reported a position in Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
  • HC Advisors's Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $60K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q4 2022.

Based on HC Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.